TruLab, Inc. (“TruLab”) launches their sample tracking technology today. TruLab’s product is aimed at giving drug sponsors an unprecedented ability to monitor drug samples in a truly end-to-end manner, from collection to repository, so that sponsors know the quality of the data they are receiving and are able to step in and fix issues with samples before samples are deemed unusable.

“Today is an exciting day in the history of our company as we officially launch our sample tracking solution,” stated Scott Ogle, Chief Executive Officer of TruLab. “This product has been in development for over a year and we are thrilled to start showcasing it to sponsors. We believe it to be the most effective sample tracking tool available and that it has the ability to revolutionize the pharmaceutical industry.”

A recent study showed that 20% of samples are lost or deemed unusable in late stage studies, and it is this issue of ruined samples that TruLab’s product is most aimed at solving. Harnessing the power of blockchain technology, TruLab’s product is able to securely monitor and track the status of every individual sample throughout the entirety of a clinical trial. The product has both a mobile application and a web component that are used in tandem by sponsors and on-site clinical site operators to track the samples.

“We have been hard at work developing this product for a long time and had no desire to launch it before it was fully operational,” said David Chung, Chief Operating Officer of TruLab. “The product that we are launching today is not only operational, but immensely effective and has the potential to completely change the efficiency of clinical trials for sponsors.”

TruLab will begin demonstrations of their product to drug sponsors effective immediately.

“Just really excited to show them what we’ve created here at TruLab,” said Chung. “There are people who have been really excited about what we’ve been doing throughout the entire development process and it’s really spectacular to be able to demonstrate the product to them and start the process of implementation into ongoing clinical trials.”

About TruLab

TruLab, Inc. is a clinical trial technology company that provides cutting edge solutions for biological sample tracking on blockchain. TruLab’s mission is to help biotechs and pharma track samples in real-time, minimize protocol deviations and eliminate paper using innovative mobile technology.  Founded in 2018, TruLab is revolutionizing biosample tracking to advance the research and development of new medical therapies.  For more information, visit www.trulab.com.